Core Lab Q3 Revenue Rises 6% to $132.1M on International Demand
HOUSTON – October 29, 2026 -- Core Laboratories (NYSE: CLB) posted third-quarter 2026 revenue of $132.1 million, up 6% sequentially and down 2% year over year, as international demand lifted both operating segments.
Ex-items operating income climbs 35% sequentially but trails last year by 24%
GAAP operating income was $12.1 million, and GAAP earnings per diluted share were $0.12. Operating income excluding items reached $12.6 million, up 35% sequentially and down 24% year over year. That yielded a 10% operating margin and sequential incremental margins of 43%. EPS excluding items was $0.16, up 46% from the prior quarter and down 27% from a year earlier.
CEO Larry Bruno cited growth in Europe-Africa, Asia-Pacific, Latin America and the Middle East, and described a "gradual improvement" in Middle East activity late in the quarter. He said geopolitical conflicts in the Middle East and Russia-Ukraine still weigh on parts of the business.